Recombinant human interleukin 6 (rhIL-6) promotes the terminal differentiation of in vivo-activated human B cells into antibody-secreting cells
- 1 February 1991
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 132 (2) , 423-432
- https://doi.org/10.1016/0008-8749(91)90039-e
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The role of human interleukin-6 in B-cell isotype regulation and differentiationCellular Immunology, 1990
- Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells.The Journal of Experimental Medicine, 1989
- Interleukin 6 gene expression in normal and neoplastic B cells.Journal of Clinical Investigation, 1989
- Cloning and Expression of the Human Interleukin-6 (BSF-2/IFNβ 2) ReceptorScience, 1988
- The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells.The Journal of Experimental Medicine, 1988
- Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression.The Journal of Experimental Medicine, 1987
- Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulinNature, 1986
- Quantitation of Blood Lymphocytes Secreting Antibodies to Pneumococcal Polysaccharides after in Vivo Antigenic StimulationScandinavian Journal of Immunology, 1986
- Identification, purification, and characterization of antigen-activated and antigen-specific human B lymphocytes.The Journal of Experimental Medicine, 1983
- Activation of Human B Lymphocytes after Immunization with Pneumococcal PolysaccharidesJournal of Clinical Investigation, 1983